348 related articles for article (PubMed ID: 29896665)
21. [Pharmacological profiles and clinical effects of amenamevir tablet as treatments for herpes zoster].
Maeda H; Nakamura H; Kikukawa Y
Nihon Yakurigaku Zasshi; 2019; 153(1):35-43. PubMed ID: 30643090
[TBL] [Abstract][Full Text] [Related]
22. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
[No Abstract] [Full Text] [Related]
23. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
Sáez-Llorens X; Yogev R; Arguedas A; Rodriguez A; Spigarelli MG; De León Castrejón T; Bomgaars L; Roberts M; Abrams B; Zhou W; Looby M; Kaiser G; Hamed K
Antimicrob Agents Chemother; 2009 May; 53(5):1912-20. PubMed ID: 19273678
[TBL] [Abstract][Full Text] [Related]
24. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
25. New antivirals with activity against varicella-zoster virus.
Gnann JW
Ann Neurol; 1994; 35 Suppl():S69-72. PubMed ID: 8185303
[TBL] [Abstract][Full Text] [Related]
26. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
[TBL] [Abstract][Full Text] [Related]
27. Valacyclovir for the treatment of genital herpes.
Brantley JS; Hicks L; Sra K; Tyring SK
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
[TBL] [Abstract][Full Text] [Related]
28. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
29. Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections.
Szenborn L; Kraszewska-Głomba B; Jackowska T; Duszczyk E; Majda-Stanisławska E; Marczyńska M; Ołdak E; Pawłowska M; Służewski W; Wysocki J; Stryczyńska-Kazubska J; Kuchar E
J Infect Chemother; 2016 Feb; 22(2):65-71. PubMed ID: 26643900
[TBL] [Abstract][Full Text] [Related]
30. HSV antivirals - current and future treatment options.
Birkmann A; Zimmermann H
Curr Opin Virol; 2016 Jun; 18():9-13. PubMed ID: 26897058
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
32. Novel agents and strategies to treat herpes simplex virus infections.
Kleymann G
Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212
[TBL] [Abstract][Full Text] [Related]
33. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.
Katsumata K; Chono K; Suzuki H
Biochem Pharmacol; 2018 Dec; 158():201-206. PubMed ID: 30365949
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
Himaki T; Masui Y; Chono K; Daikoku T; Takemoto M; Haixia B; Okuda T; Suzuki H; Shiraki K
Antiviral Res; 2012 Feb; 93(2):301-304. PubMed ID: 22155691
[TBL] [Abstract][Full Text] [Related]
35. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
36. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
Beutner KR
Antiviral Res; 1995 Dec; 28(4):281-90. PubMed ID: 8669888
[TBL] [Abstract][Full Text] [Related]
37. Management of herpes simplex and varicella-zoster virus infections.
Erlich KS
West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
[TBL] [Abstract][Full Text] [Related]
38. Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes.
Takada A; Katashima M; Kaibara A; Sawamoto T; Zhang W; Keirns J
Clin Pharmacol Drug Dev; 2014 Sep; 3(5):365-70. PubMed ID: 27129009
[TBL] [Abstract][Full Text] [Related]
39. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
Safrin S
Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
[No Abstract] [Full Text] [Related]
40. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
